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eAppendix 1. Data Extraction Steps 
Methods  
In this appendix, we first describe the following major tasks that we have accomplished for 
data extraction: 
(1) Use filters to clean the data 
(2) Capture various preoperative laboratory values  
(3) Create postoperative outcomes  
These tasks are outlined sequentially on the following pages. For other outcomes (pneumonia, 
DVT, PE and delirium), refer to “SATISFY-SOS Pilot Study – Algorithm for Automated 
Medical Record Review” at the end of this appendix.  
TASK 1: Use filters to clean the data 
• In the laboratory files (including the creatinine files, preoperative labs, and in-hospital 
labs) 
o Eliminate rows where NORMALIZED_RESULT is a text value rather than a 
number. 
o Eliminate rows with excluded LAB_CODE based on eTable 1.  (This is primarily 
to exclude tests being run on fluids other than blood.) 
o  
eTable 1. Lab Codes to Include and Exclude for Laboratory Values 
Laboratory Value LAB CODE to Include LAB CODE to Exclude 
Alanine Transaminase (ALT) 445072  
Albumin 132 3620 
141104 
158014 







































Urea Nitrogen (BUN) 1456 
8765 
7026 





TASK 2: Capture preoperative laboratory values  
• For each lab test listed in Table 1, identify the value that is closest to the anesthesia start 
time, but is still before the anesthesia start time. 
o Consider all similarly-named variables as a group. (For example, the preoperative 
bicarbonate would be the value closest to anesthesia start, regardless of whether it 
is lab code 4126 or 5297) 
o Include labs drawn up to 30 days before the anesthesia start time. 
o If a patient did not have a particular lab drawn, then treat that field as missing. 
Thus each patient should have variables called “pre op ALT,” “pre op albumin,” and so on. 
TASK 3: Create two variables for postoperative complications: Acute kidney injury (AKI) 
The first variable uses creatinine values to define AKI. A patient has an AKI if the creatinine 
rises by 0.3 mg/dl or by 50% of its preoperative value within the first 48 hours after surgery. 
The second variable uses new onset of renal replacement therapy (dialysis) to define AKI.  A 
patient has an AKI if they were not on dialysis before surgery and they needed dialysis after 
surgery prior to discharge.  
Patients are excluded if they are undergoing kidney transplant or if they are undergoing 
creation or revision of dialysis access (for example, arteriovenous fistula, ateriovenous graft).  
eTable 2 at the end of this section contains CPT codes for these procedures, eTable 3 contains 
ICD-9-CM codes, and Table 4 contains ICD-10-PCS codes. 
(1) Acute Kidney Injury – Creatinine Definition 
This calculation requires the CKD_DialysisHistory variable. 
• Set the AKI_Creatinine variable to missing if any of the following are true 
o CKD_DialysisHistory = “ongoing hemodialysis” or “ongoing peritoneal dialysis” 
o Preoperative creatinine is missing 
o Postoperative creatinine peak is missing 
o Procedure code matches a CPT code in Table 2, ICD-9-CM code in Table 3, or 
ICD-10-PCS code in Table 4.  (In other words, patient is undergoing kidney 
transplant or dialysis access procedure) 
• Set the AKI_Creatinine variable to 1 if any of the following are true 
o Postoperative peak creatinine >= Preoperative creatinine + 0.3 
o Postoperative peak creatinine >= 1.5 * Preoperative creatinine 
• Otherwise set the AKI_Creatinine variable to 0 
(2) Acute Kidney Injury – Dialysis Definition 
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This calculation requires the M_Kidney_Dialysis variable and the CKD_DialysisHistory 
variable. 
• Set the AKI_Dialysis variable to missing if any of the following are true 
o CKD_DialysisHistory = “ongoing hemodialysis” or “ongoing peritoneal dialysis” 
o Procedure code matches a CPT code in Table 2, ICD-9-CM code in Table 3, or 
ICD-10-PCS code in Table 4.  (In other words, patient is undergoing kidney 
transplant or dialysis access procedure) 
• Set the AKI_Dialysis variable to 1 if M_Kidney_Dialysis = 1 
• Otherwise set the AKI_Dialysis variable to 0.  (This includes cases where 
M_Kidney_Dialysis = 0 and cases where M_Kidney_Dialysis is missing.) 
 
eTable 2. CPT Codes for Kidney Transplant and Dialysis Access Procedures 
36818  Upper arm cephalic transposition 
36819 Upper arm basilic vein transposition 
36820  Forearm any vein transposition 
36821 AV access with direct vein to artery anastomosis 
36825 AV access with other than direct ateriovenous anastomosis; autogenous graft 
36830 AV access with other than direct arteriovenous anastomosis; non-autogenous graft 
36831 Thrombectomy of AVF, open, no revision 
36832 Revision of AVF, open, no thrombectomy 
36833 Revision of AVF and thrombectomy, open 
50360 Renal allotransplantation; implementation of graft, excluding donor and recipient 
nephrectomy 
50365 Renal allotransplantation, implantation of graft; with recipient nephrectomy 
 
eTable 3. ICD-9-CM Codes for Kidney Transplant and Dialysis Access Procedures 
39.27 Arteriovenostomy for renal dialysis 
39.42  Revision of arteriovenous shunt for renal dialysis 
39.43  Removal of arteriovenous shunt for renal dialysis 
55.6  Other kidney transplantation 
39.42  Revision of arteriovenous shunt for renal dialysis 
 
eTable 4. ICD-10-PCS Codes for Kidney Transplant and Dialysis Access Procedures 
0TY00Z0  Transplantation of right kidney, allogeneic, open approach 
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0TY00Z1  Transplantation of right kidney, syngeneic, open approach 
0TY10Z0  Transplantation of left kidney, allogeneic, open approach 
0TY10Z1  Transplantation of left kidney, syngeneic, open approach 
031209D Bypass Innominate Artery to Upper Arm Vein with Autologous Venous Tissue, Open 
Approach 
031209F Bypass Innominate Artery to Lower Arm Vein with Autologous Venous Tissue, Open 
Approach 
03120AD Bypass Innominate Artery to Upper Arm Vein with Autologous Arterial Tissue, Open 
Approach 
03120AF Bypass Innominate Artery to Lower Arm Vein with Autologous Arterial Tissue, Open 
Approach 
03120JD Bypass Innominate Artery to Upper Arm Vein with Synthetic Substitute, Open Approach 
03120JF Bypass Innominate Artery to Lower Arm Vein with Synthetic Substitute, Open Approach 
03120KD Bypass Innominate Artery to Upper Arm Vein with Nonautologous Tissue Substitute, 
Open Approach 
03120KF Bypass Innominate Artery to Lower Arm Vein with Nonautologous Tissue Substitute, 
Open Approach 
03120ZD Bypass Innominate Artery to Upper Arm Vein, Open Approach 
03120ZF Bypass Innominate Artery to Lower Arm Vein, Open Approach 
031309D Bypass Right Subclavian Artery to Upper Arm Vein with Autologous Venous Tissue, 
Open Approach 
031309F Bypass Right Subclavian Artery to Lower Arm Vein with Autologous Venous Tissue, 
Open Approach 
03130AD Bypass Right Subclavian Artery to Upper Arm Vein with Autologous Arterial Tissue, 
Open Approach 
03130AF Bypass Right Subclavian Artery to Lower Arm Vein with Autologous Arterial Tissue, 
Open Approach 
03130JD Bypass Right Subclavian Artery to Upper Arm Vein with Synthetic Substitute, Open 
Approach 
03130JF Bypass Right Subclavian Artery to Lower Arm Vein with Synthetic Substitute, Open 
Approach 
03130KD Bypass Right Subclavian Artery to Upper Arm Vein with Nonautologous Tissue 
Substitute, Open Approach 
03130KF Bypass Right Subclavian Artery to Lower Arm Vein with Nonautologous Tissue 
Substitute, Open Approach 
03130ZD Bypass Right Subclavian Artery to Upper Arm Vein, Open Approach 
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03130ZF Bypass Right Subclavian Artery to Lower Arm Vein, Open Approach 
031409D Bypass Left Subclavian Artery to Upper Arm Vein with Autologous Venous Tissue, Open 
Approach 
031409F Bypass Left Subclavian Artery to Lower Arm Vein with Autologous Venous Tissue, Open 
Approach 
03140AD Bypass Left Subclavian Artery to Upper Arm Vein with Autologous Arterial Tissue, Open 
Approach 
03140AF Bypass Left Subclavian Artery to Lower Arm Vein with Autologous Arterial Tissue, Open 
Approach 
03140JD Bypass Left Subclavian Artery to Upper Arm Vein with Synthetic Substitute, Open 
Approach 
03140JF Bypass Left Subclavian Artery to Lower Arm Vein with Synthetic Substitute, Open 
Approach 
03140KD Bypass Left Subclavian Artery to Upper Arm Vein with Nonautologous Tissue Substitute, 
Open Approach 
03140KF Bypass Left Subclavian Artery to Lower Arm Vein with Nonautologous Tissue Substitute, 
Open Approach 
03140ZD Bypass Left Subclavian Artery to Upper Arm Vein, Open Approach 
03140ZF Bypass Left Subclavian Artery to Lower Arm Vein, Open Approach 
031509D Bypass Right Axillary Artery to Upper Arm Vein with Autologous Venous Tissue, Open 
Approach 
031509F Bypass Right Axillary Artery to Lower Arm Vein with Autologous Venous Tissue, Open 
Approach 
03150AD Bypass Right Axillary Artery to Upper Arm Vein with Autologous Arterial Tissue, Open 
Approach 
03150AF Bypass Right Axillary Artery to Lower Arm Vein with Autologous Arterial Tissue, Open 
Approach 
03150JD Bypass Right Axillary Artery to Upper Arm Vein with Synthetic Substitute, Open 
Approach 
03150JF Bypass Right Axillary Artery to Lower Arm Vein with Synthetic Substitute, Open 
Approach 
03150KD Bypass Right Axillary Artery to Upper Arm Vein with Nonautologous Tissue Substitute, 
Open Approach 
03150KF Bypass Right Axillary Artery to Lower Arm Vein with Nonautologous Tissue Substitute, 
Open Approach 
03150ZD Bypass Right Axillary Artery to Upper Arm Vein, Open Approach 
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03150ZF Bypass Right Axillary Artery to Lower Arm Vein, Open Approach 
031609D Bypass Left Axillary Artery to Upper Arm Vein with Autologous Venous Tissue, Open 
Approach 
031609F Bypass Left Axillary Artery to Lower Arm Vein with Autologous Venous Tissue, Open 
Approach 
03160AD Bypass Left Axillary Artery to Upper Arm Vein with Autologous Arterial Tissue, Open 
Approach 
03160AF Bypass Left Axillary Artery to Lower Arm Vein with Autologous Arterial Tissue, Open 
Approach 
03160JD Bypass Left Axillary Artery to Upper Arm Vein with Synthetic Substitute, Open Approach 
03160JF Bypass Left Axillary Artery to Lower Arm Vein with Synthetic Substitute, Open 
Approach 
03160KD Bypass Left Axillary Artery to Upper Arm Vein with Nonautologous Tissue Substitute, 
Open Approach 
03160KF Bypass Left Axillary Artery to Lower Arm Vein with Nonautologous Tissue Substitute, 
Open Approach 
03160ZD Bypass Left Axillary Artery to Upper Arm Vein, Open Approach 
03160ZF Bypass Left Axillary Artery to Lower Arm Vein, Open Approach 
031709D Bypass Right Brachial Artery to Upper Arm Vein with Autologous Venous Tissue, Open 
Approach 
031709F Bypass Right Brachial Artery to Lower Arm Vein with Autologous Venous Tissue, Open 
Approach 
03170AD Bypass Right Brachial Artery to Upper Arm Vein with Autologous Arterial Tissue, Open 
Approach 
03170AF Bypass Right Brachial Artery to Lower Arm Vein with Autologous Arterial Tissue, Open 
Approach 
03170JD Bypass Right Brachial Artery to Upper Arm Vein with Synthetic Substitute, Open 
Approach 
03170JF Bypass Right Brachial Artery to Lower Arm Vein with Synthetic Substitute, Open 
Approach 
03170KD Bypass Right Brachial Artery to Upper Arm Vein with Nonautologous Tissue Substitute, 
Open Approach 
03170KF Bypass Right Brachial Artery to Lower Arm Vein with Nonautologous Tissue Substitute, 
Open Approach 
03170ZD Bypass Right Brachial Artery to Upper Arm Vein, Open Approach 
03170ZF Bypass Right Brachial Artery to Lower Arm Vein, Open Approach 
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031809D Bypass Left Brachial Artery to Upper Arm Vein with Autologous Venous Tissue, Open 
Approach 
031809F Bypass Left Brachial Artery to Lower Arm Vein with Autologous Venous Tissue, Open 
Approach 
03180AD Bypass Left Brachial Artery to Upper Arm Vein with Autologous Arterial Tissue, Open 
Approach 
03180AF Bypass Left Brachial Artery to Lower Arm Vein with Autologous Arterial Tissue, Open 
Approach 
03180JD Bypass Left Brachial Artery to Upper Arm Vein with Synthetic Substitute, Open Approach 
03180JF Bypass Left Brachial Artery to Lower Arm Vein with Synthetic Substitute, Open 
Approach 
03180KD Bypass Left Brachial Artery to Upper Arm Vein with Nonautologous Tissue Substitute, 
Open Approach 
03180KF Bypass Left Brachial Artery to Lower Arm Vein with Nonautologous Tissue Substitute, 
Open Approach 
03180ZD Bypass Left Brachial Artery to Upper Arm Vein, Open Approach 
03180ZF Bypass Left Brachial Artery to Lower Arm Vein, Open Approach 
031909F Bypass Right Ulnar Artery to Lower Arm Vein with Autologous Venous Tissue, Open 
Approach 
03190AF Bypass Right Ulnar Artery to Lower Arm Vein with Autologous Arterial Tissue, Open 
Approach 
03190JF Bypass Right Ulnar Artery to Lower Arm Vein with Synthetic Substitute, Open Approach 
03190KF Bypass Right Ulnar Artery to Lower Arm Vein with Nonautologous Tissue Substitute, 
Open Approach 
03190ZF Bypass Right Ulnar Artery to Lower Arm Vein, Open Approach 
031A09F Bypass Left Ulnar Artery to Lower Arm Vein with Autologous Venous Tissue, Open 
Approach 
031A0AF Bypass Left Ulnar Artery to Lower Arm Vein with Autologous Arterial Tissue, Open 
Approach 
031A0JF Bypass Left Ulnar Artery to Lower Arm Vein with Synthetic Substitute, Open Approach 
031A0KF Bypass Left Ulnar Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open 
Approach 
031A0ZF Bypass Left Ulnar Artery to Lower Arm Vein, Open Approach 
031B09F Bypass Right Radial Artery to Lower Arm Vein with Autologous Venous Tissue, Open 
Approach 
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031B0AF Bypass Right Radial Artery to Lower Arm Vein with Autologous Arterial Tissue, Open 
Approach 
031B0JF Bypass Right Radial Artery to Lower Arm Vein with Synthetic Substitute, Open Approach 
031B0KF Bypass Right Radial Artery to Lower Arm Vein with Nonautologous Tissue Substitute, 
Open Approach 
031B0ZF Bypass Right Radial Artery to Lower Arm Vein, Open Approach 
031C09F Bypass Left Radial Artery to Lower Arm Vein with Autologous Venous Tissue, Open 
Approach 
031C0AF Bypass Left Radial Artery to Lower Arm Vein with Autologous Arterial Tissue, Open 
Approach 
031C0JF Bypass Left Radial Artery to Lower Arm Vein with Synthetic Substitute, Open Approach 
031C0KF Bypass Left Radial Artery to Lower Arm Vein with Nonautologous Tissue Substitute, 
Open Approach 
031C0ZF Bypass Left Radial Artery to Lower Arm Vein, Open Approach 
03PY07Z Removal of Autologous Tissue Substitute from Upper Artery, Open Approach 
03PY0JZ Removal of Synthetic Substitute from Upper Artery, Open Approach 
03PY0KZ Removal of Nonautologous Tissue Substitute from Upper Artery, Open Approach 
03PY37Z Removal of Autologous Tissue Substitute from Upper Artery, Percutaneous Approach 
03PY3JZ Removal of Synthetic Substitute from Upper Artery, Percutaneous Approach 
03PY3KZ Removal of Nonautologous Tissue Substitute from Upper Artery, Percutaneous Approach 
03PY47Z Removal of Autologous Tissue Substitute from Upper Artery, Percutaneous Endoscopic 
Approach 
03PY4JZ Removal of Synthetic Substitute from Upper Artery, Percutaneous Endoscopic Approach 
03PY4KZ Removal of Nonautologous Tissue Substitute from Upper Artery, Percutaneous 
Endoscopic Approach 
 
SATISFY-SOS Pilot Study – Algorithm for Automated Medical Record Review for all 
other Postoperative Complications 
TASK 1: Identify the target date range 
A. Variables to be used in this procedure  
a. OR_Date – This is the date that triggered our team to send a survey to the patient.  
It is defined as the first time the patient received a billable anesthesia service at a 
BJC facility starting two weeks prior to the date of study consent.  It is often, but 
not always, the same as the procedure of interest.  There are no missing values. 
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b. PAP_Type – This is a categorical variable indicating where the patient underwent 
preoperative assessment by the anesthesiology department.  Possible values 
include 
i. “CPAP Clinic” – assessed at Center for Preoperative Assessment and 
Planning, an outpatient clinic 
ii. “CPAP-incomplete” – assessed at CPAP, but data form is <75% complete 
iii. “DPAP (holding area)” – assessed on day of surgery in preop holding area 
iv. “DPAP (on ward)” – assessed on day of surgery on hospital ward 
v. “IPAP” – assessed as an inpatient, prior to day of surgery 
vi. “IPAP-incomplete” – assessed as inpatient, but data form is <75% 
complete 
vii. “TPAP-AP” – assessed by telephone 
viii. “TPAP-RN” – assessed by telephone by a nurse 
c. PAP_Date – This is the date that the patient underwent their CPAP, DPAP, IPAP, 
or TPAP.  In most cases, this is also the date of study consent. 
d. CPAP_DOSPlanned – This is the date of anticipated surgery, as documented in 
the preoperative assessment note.  The value is missing for about 50% of patients 
in our study.  If the patient has a surgery on this date, it is likely the procedure of 
interest. 
 
B. Identify the date of the procedure of interest 
a. If PAP_Type = “IPAP” or “IPAP-incomplete” or “DPAP (holding area)” or 
“DPAP (on ward)” or “TPAP-AP” or “TPAP-RN” OR if PAP_Type = 
[missing] 
i. Then OR_Date gives the date of the procedure of interest. 
Patients who did not go the CPAP clinic must have been consented during 
the hospitalization for the procedure of interest.  It is safe to assume that 
these patients have not had additional billable anesthesia services in the 
past two weeks that were not associated with the current hospitalization.  
Therefore OR_Date accurately gives the date of the procedure of interest. 
 
b. If PAP_Type = “CPAP Clinic” or “CPAP-incomplete” AND OR_Date = 
CPAP_DOSPlanned 
i. Then OR_Date gives the date of the procedure of interest. 
These criteria select patients who were seen in CPAP, had the procedure 
of interest on the originally scheduled date, and did not undergo any 
minor procedure between the CPAP visit and the procedure of interest.   
 
c. If PAP_Type = “CPAP Clinic” or “CPAP-incomplete” AND OR_Date ≠ 
CPAP_DOSPlanned (including cases where CPAP_DOSPlanned = [missing]) 
These criteria select patients with any of the following conditions: (1) Patient had 
a minor procedure, and then had their planned procedure of interest on the 
originally scheduled day.  (2) Patient had a minor procedure, and then had their 
planned procedure of interest on a day other than the originally scheduled day. 
(3) Patient had no minor procedure, but had their planned procedure of interest 
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on a day other than the originally scheduled day.  (4) Patient had a minor 
procedure, and did not have their planned procedure of interest. 
i. Then search for “Anesthesia Record” document with a date matching 
“CPAP_DOSPlanned”.  If there is a match, then “CPAP_DOSPlanned” 
gives the date of the procedure of interest.  If there is no match, continue 
to the next step.  If “CPAP_DOSPlanned” is missing, skip this step. 
This covers situation (1) above. 
ii. If neither of the above searches yields a result, then use “OR_Date” as the 
date of the procedure of interest. 
This covers situations (2), (3), and (4) above.  For situation (2), we have 
identified the incorrect procedure but do not have sufficient information to 
find the procedure of interest.  For situation (3), we have identified the 
procedure of interest.  For situation (4), realize that the patient never had 
the intended procedure of interest, so chart review will focus on the minor 
procedure. 
 
C. Identify the visit number (starts with 701… in most cases) associated with the date of 
the procedure of interest.  This is included in the “Anesthesia Record” document, which 
all patients in the study will have.  It is also in the operative summary document, but 
some patients in our study undergo procedures (i.e. electrophysiology) that do not 
generate that document.   
 
D. Restrict search for complications to data corresponding to this visit number.  Examine 
complications that occurred during hospitalization for the procedure of interest. 
 
TASK 2: Identify complications occurring within the target date range 
For all subsequent steps, restrict the search to data corresponding to the visit number identified 
in Task 1. In general, searches of ICD-9 diagnosis codes should exclude the admitting diagnosis, 
as the admitting diagnosis should be the indication for surgery and would be unlikely to 
represent a postoperative complication.  Note that the admitting diagnosis is typically repeated in 
the list of final diagnoses.  It should still be excluded from searches. 
Variables to be used in this procedure: 
- AFIB – This is a dichotomous variable (check box) from the preoperative assessment 
form, indicating whether the patient reports a history of atrial fibrillation or atrial flutter.  
Possible values are 1 (yes) and 0 (no).  If there are missing values, assume a value of 0. 
- AFIB_Rhythm – This is a categorical variable (select from menu) from the preoperative 
assessment form, indicating the patient’s current heart rhythm.  Possible values include 
“atrial fibrillation,” “atrial flutter,” “non-fibrillation/flutter,” and “indeterminate.”  
This variable is only defined if AFIB = 1. 
- CKD – This is a dichotomous variable (check box) from the preoperative assessment 
form, indicating whether the patient reports a history of chronic kidney disease.  Possible 
values are 1 (yes) and 0 (no).  If there are missing values, assume a value of 0. 
- CKD_DialysisHistory – This is a categorical variable (select from menu) from the 
preoperative assessment form, indicating if the patient is currently receiving dialysis or 
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has done so previously.  Possible values include “never,” “ongoing peritoneal dialysis,” 
“ongoing hemodialysis,” and “past dialysis.”  This variable is only defined if CKD = 1. 
 
A. Blood clot in your leg 
Chronic deep venous thrombosis and venous thrombosis outside of the leg are excluded. 
Chart review is positive for this complication if this criterion is met: 
a. ANY of the following ICD-9 codes are listed as a final diagnosis and not listed as 
the admitting diagnosis 
i. 453.4X (Acute venous embolism and thrombosis of deep vessels of lower 
extremity) 
 
B. Blood clot in your lung 
Chart review is positive for this complication if this criterion is met: 
a. ANY of the following ICD-9 codes are listed as a final diagnosis and not listed as 
the admitting diagnosis 
i. 415.1X (Pulmonary embolism and infarction) 
 
C. An infection in your lungs (pneumonia) 
Chart review is positive for this complication if this criterion is met: 
a. ANY of the following ICD-9 codes are listed as a final diagnosis and not listed as 
the admitting diagnosis 
i. 011.6X (Tuberculous pneumonia) 
ii. 073.0 (Ornithosis with pneumonia) 
iii. 112.4 (Candidiasis of lung) 
iv. 136.3 (Pneumocystosis) 
v. 480.X (Viral pneumonia) 
vi. 481 (Pneumococcal pneumonia) 
vii. 482.X (Other bacterial pneumonia) 
viii. 483.X (Pneumonia due to other specified organism) 
ix. 484.X (Pneumonia in infectious diseases classified elsewhere) 
x. 485 (Bronchopneumonia, organism unspecified) 
xi. 486 (Pneumonia, organism unspecified) 
xii. 487.0 (Influenza with pneumonia) 
xiii. 510.X (Empyema) 
xiv. 997.31 (Ventilator associated pneumonia) 
xv. 997.32 (Postprocedural aspiration pneumonia) 
 
D. Kidney failure and you needed dialysis 
Chart review is positive for this complication if BOTH of the following criteria are met: 
a. ANY of the following ICD-9 codes are listed as a procedure 
i. 39.95 (Hemodialysis) 
ii. 54.98 (Peritoneal dialysis) 
b. The patient is not a home dialysis patient.  Must meet AT LEAST ONE of the 
following criteria   
i. CKD = 0 or [missing] 
The patient did not have known kidney disease preoperatively. 
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ii. CKD = 1 AND CKD_DialysisHistory = “Never” or “Past dialysis” or 
[missing] 
The patient had known kidney disease preoperatively, but was not 
receiving ongoing hemodialysis or peritoneal dialysis. 
E. Delirium 
Chart review is positive for this complication if this criterion is met: 
a. ANY of the following ICD-9 codes are listed as a final diagnosis and not listed as 
the admitting diagnosis 
i. 290.11 (Presenile dementia with delirium) 
ii. 290.3 (Senile dementia, with delirium) 
iii. 290.41 (Vascular dementia, with delirium) 
iv. 291.0 (Alcohol withdrawal delirium) 
v. 292.81 (Drug-induced delirium) 
vi. 293.0 (Delirium due to conditions classified elsewhere) 
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eAppendix 2.  List of Variables and Data Type 
eTable 5. The list of preoperative variables, missing rates, total records, and data type 
Variable Availability 
rate 
Total records Count of 
missing data 
Data Type 
Hypertension 100.00% 111929 0 binary 
Coronary Arterial Disease 100.00% 111929 0 binary 
History of Myocardial 
Infraction 
100.00% 111929 0 binary 
Congestive Heart Failure 100.00% 111929 0 binary 
Permanent Pacemaker 100.00% 111929 0 binary 
History of Stroke 100.00% 111929 0 binary 
Peripheral Artery Disease 100.00% 111929 0 binary 
Deep Venous Thrombosis 100.00% 111929 0 binary 
Pulmonary Embolism 100.00% 111929 0 binary 
Diabetes Mellitus 100.00% 111929 0 binary 
Chronic Kidney Disease 100.00% 111929 0 binary 
Pulmonary Hypertension 100.00% 111929 0 binary 
Chronic Obstructive 
Pulmonary Disease 
100.00% 111929 0 binary 
Asthma 100.00% 111929 0 binary 
Obstructive Sleep Apnea 100.00% 111929 0 binary 
Cirrhosis 100.00% 111929 0 binary 
Cancer History 100.00% 111929 0 binary 
Gastroesophageal Reflux 
Disease 
100.00% 111929 0 binary 
Anemia 100.00% 111929 0 binary 
Coombs Positive 100.00% 111929 0 binary 
Dementia 100.00% 111929 0 binary 
Peptic Ulcer 100.00% 111929 0 binary 
LVEF (Left ventricular 
ejection fraction) 
99.99% 111918 11 discrete [31, 38] 
Outpatient Insulin Use 99.98% 111910 19 binary 
ASA 99.98% 111902 27 discrete [1,6] 
Valvular Disease 99.90% 111819 110 discrete [60, 65] 
Left Ventricular Diastolic 
Function 
99.71% 111604 325 discrete [20. 23] 
Dialysis History 99.64% 111529 400 binary 
Sex 99.04% 110858 1071 categorical 
Age 99.03% 110846 1083 continuous 
Preop Heart Rate 98.94% 110743 1186 continuous 
Preop Spo2 98.89% 110684 1245 continuous 
Weight 98.82% 110611 1318 continuous 
CCI 98.48% 110223 1706 discrete [0,15] 
Race 95.33% 106705 5224 categorical 
Height 93.98% 105187 6742 continuous 
BMI 93.91% 105113 6816 continuous 
Ideal Body Weight 93.09% 104191 7738 continuous 
Smoking Habits 91.29% 102185 9744 binary 
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Glucose 76.54% 85676 26253 continuous 
Hematocrit 75.83% 84878 27051 continuous 
Sodium 75.01% 83959 27970 continuous 
Potassium 75.00% 83951 27978 continuous 
Urea Nitrogen 74.88% 83818 28111 continuous 
Creatinine 73.91% 82728 29201 continuous 
White Blood Cells 73.81% 82612 29317 continuous 
Preop Systolic 42.58% 47655 64274 continuous 
Preop Diastolic 42.57% 47649 64280 continuous 
Functional Capacity 42.24% 47284 64645 discrete [6, 9] 
Partial Thromboplastin Time 39.82% 44574 67355 continuous 
Planned Surgery Type 39.07% 43736 68193 categorical 
Albumin 34.18% 38256 73673 continuous 
Alkaline Phosphatase 33.88% 37917 74012 continuous 
Alanine Aminotransferase 
Level 
33.87% 37908 74021 continuous 
History of Delirium 11.54% 12919 99010 binary 
Atrial Fibrillation 2.09% 2340 109589 discrete (4,7] 
Platelets 1.76% 1967 109962 continuous 
 
eTable6: The list of intraoperative variables, missing rates and total records 
Variable Name Number of Patients Availability Rate 
SpO2 109819 98.11% 
Heart Rate 109816 98.11% 
Respiration rate 109796 98.09% 
Pulse 109735 98.04% 
O2 inspiratory 
concentration 109157 97.52% 
ETCO2 (mmHg) 109009 97.39% 
Systolic Blood Pressure 
non-invasive 106672 95.30% 
Diastolic blood pressure 
non-invasive 106665 95.30% 
Mean blood pressure - 
non-invasive 106599 95.24% 
Peak inspiratory pressure 102907 91.94% 
Tidal Volume 98227 87.76% 
BJ Temp (Centigrade) 98186 87.72% 
Respiratory Minute 
Volume 97602 87.20% 
TOTALMAC(minimum 
alveolar concentration) 97390 87.01% 
TOTALMACAGEADJ 
(TOTALMAC normalized 
to patient’s age) 
97390 87.01% 
PEEP 96169 85.92% 
Urine output 73711 65.86% 




concentration 68853 61.51% 
Sevoflurane inspiratory 
concentration 68763 61.43% 
Phenylephrine 66058 59.02% 
Estimated blood loss 61004 54.50% 
Desflurane expiratory 
concentration 52779 47.15% 
Desflurane inspiratory 
concentration 52678 47.07% 
Plateau pressure 33805 30.21% 
N2O expiratory 
concentration 31762 28.38% 
Phenylephrine fluid 30950 27.68% 
Mean Blood Pressure - 
Invasive 26592 23.83% 
N2O inspiratory 
concentration 26204 23.50% 
BJ N Systolic Blood 
Pressure invasive 25950 23.41% 
Diastolic blood pressure 
invasive 25846 23.32% 
Norepinephrine_fluid 9026 8.15% 
Central Venous Pressure 8951 8.09% 
Norepinephrine 7529 6.81% 
Bispectral Index 7395 6.71% 
BIS EMG (Detected 
muscle activity from a 
BIS probe) 
7192 6.74% 
HCT (Hematocrit) 7017 6.67% 
POTASSIUM 6982 6.64% 
Epinephrine 6429 6.17% 
BIS SEF (Spectral edge 
frequency measured from 
a BIS probe) 
6235 6.10% 
Isoflurane expiratory 
concentration 6207 7.24% 
Isoflurane inspiratory 
concentration 6136 7.23% 
BIS SR (Burst 
suppression measured 
from a BIS probe) 
5536 6.59% 
SECSURPPRESSED 
(Transformation of BIS 
SR) 
5564 6.63% 
PCO2 Arterial POC 5390 6.43% 
PH Arterial POC 5390 6.52% 
PO2 Arterial POC 5390 6.52% 
Glucose Arterial POC 5376 11.28% 
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Bicarb Arterial POC 5214 10.94% 
Base Excess Arterial POC 5139 10.87% 
Dobutamine fluid 2866 6.43% 
Vasopressin fluid 2779 6.35% 
Epinephrine fluid 2226 5.82% 
GLUCOSE Venous POC 1743 4.60% 
PLATELET 1499 3.95% 
BJ T Core 1151 8.91% 
INR (International 
Normalized Ratio, a 
measure of blood 
coagulation function) 
522 22.31% 
BIS TP (Total power 
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eAppendix 3. Exploration on Data Imputation 
eMethods 2 
In this section, we have conducted comparison between 7 most common data imputation 
techniques: mode, mean, median, dummy indication, Multiple Imputation by Chained Equations2 
(with 10 iterations), MissForest3 (with 10 iterations), and kNN imputation. Due to the selection 
of hyper-parameters in kNN, we further implemented kNN with number of nearest neighbors =3 
and uniform weights, and number of nearest neighbors =5 and distance-based weights. In total, 8 
imputation methods were compared.  
The experiment was designed using pneumonia dataset in 3 steps. First, each imputation method 
was performed on a copy of the original pneumonia dataset, and the imputed values for the 
nominal (categorical) variables were rounded to the closest values in the original distribution. By 
doing so, the range of each variable was reserved. With 8 imputation methods implemented, we 
ended up with 8 imputed datasets. Second, each imputed dataset was processed in the same way 
as described in the manuscript. The categorical variables were split into binary variables by one-
hot-encoding, and continuous variables were normalized by z-scoring. Last, each processed 
dataset was evaluated by gradient boosting tree (GBT), random forest (RF) and logistic 
regression (LR) with 5 random shuffles of cross validation. The configuration of GBT, RF and 
LR was the same as in the manuscript.  
The performance of each imputation method was tabulated in eTable 1. As clearly shown in the 
table, regardless of imputation methods that we used, GBT had the best performance in terms of 
both AUROC and AUPRC. Moreover, regardless of any machine learning models used, we 
observed that the imputed dataset using dummy indicator was most predictive. This might be 
explained by the fact that some measurements, especially lab tests, are missing by “intention”: 
when clinicians decide not to perform a lab test on a patient, it reflects the clinicians’ opinion 
that the lab result is expected to be normal. As a result, the indication of missingness in dummy 
indicator method preserves this “intention” of clinicians, hence the imputed dataset becomes 
more informative.  
eTable7: The comparison of imputation methods  
Imputation Method AUROC AUPRC 
GBT 
Dummy Indicator 0.905 (0.903,0.907) 0.208 (0.203,0.213) 
Mean 0.901 (0.898,0.904) 0.206 (0.199,0.213) 
Median 0.901 (0.898,0.904) 0.204 (0.199,0.210) 
Mode 0.902 (0.900,0.904) 0.203 (0.198,0.208) 
kNN-3 0.884 (0.882,0.887) 0.182 (0.176,0.188) 
kNN-5 0.884 (0.882,0.887) 0.182 (0.176,0.188) 
MICE 0.893 (0.890,0.896) 0.193 (0.187,0.200) 
MissForest 0.890 (0.888,0.893) 0.184 (0.178,0.189) 
LR 
Dummy Indicator 0.896 (0.892,0.899) 0.187 (0.181,0.193) 
Mean 0.88 (0.877,0.883) 0.177 (0.171,0.182) 
Median 0.884 (0.881,0.887) 0.178 (0.173,0.184) 
Mode 0.89 (0.887,0.892) 0.181 (0.175,0.186) 
kNN-3 0.872 (0.869,0.874) 0.161 (0.156,0.166) 
© 2021 Xue B et al. JAMA Network Open. 
 
 
kNN-5 0.871 (0.868,0.874) 0.161 (0.156,0.165) 
MICE 0.878 (0.875,0.880) 0.16 (0.157,0.163) 
MissForest 0.879 (0.877,0.882) 0.161 (0.157,0.165) 
RF 
Dummy Indicator 0.892 (0.889,0.894) 0.17 (0.165,0.175) 
Mean 0.887 (0.884,0.890) 0.168 (0.163,0.173) 
Median 0.886 (0.884,0.889) 0.169 (0.163,0.174) 
Mode 0.887 (0.884,0.890) 0.167 (0.162,0.172) 
kNN-3 0.867 (0.864,0.869) 0.145 (0.139,0.152) 
kNN-5 0.867 (0.864,0.869) 0.145 (0.139,0.152) 
MICE 0.871 (0.868,0.874) 0.149 (0.142,0.155) 
MissForest 0.836 (0.764,0.908) 0.135 (0.123,0.148) 
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eAppendix 4.  Model Development 
eMethods 3  
For support vector machine (SVM), the regularizer was set to l2 norm to avoid overfitting and 
loss function was set to squared hinge loss. Due to the large number of records in the dataset, a 
linear SVM was used. In logistic regression (LR), Newton-CG solver was used for its optimal 
performance in large datasets. The hyper-parameters of random forest (RF) and deep neural 
network (DNN) were chosen by grid search. In RF, we varied the number of base learners from 
40 to 300, maximum depth from 20 to 200, and minimum samples for splits from 1 to 7. The 
optimal hyper parameters for RF were 300 base learners, 200 maximum depth, and minimum 4 
samples for splits.  For DNN models, we explored both 3-layer, 4-layer and 5-layer architecture 
by varying number of nodes in each layer. When exploring the optimal DNN architecture, we 
varied the number of nodes in the first layer as 16, 32, 64, 128. The number of nodes in the 
second layer was chosen as half of the first layer accordingly, the number of nodes in third layer 
was chosen as half of the second layer, and so on. The last layer of DNN model was always 
unchanged and had 2 nodes, as it directly connected to the softmax layer to generate probabilistic 
output. The optimal configuration of DNN had 4 layers with 128, 64, 32, and 2 nodes in each 
layer).  When training the DNN model, we further explored the choice of learning rate as 0.0001, 
0.001, 0.01 and different batch size options as 32, 64, 128, 256, 512, 1024, 2048. The optimal 
settings are choosing learning rate as 0.001 and batch size as 2048. Gradient boosting tree (GBT) 
was created by setting tree-based learners and logistic loss function. Note that different versions 
of GBT may affect model performance, due to parameter setting. Version list and Python codes 
are uploaded to Github: xuebing1234/handoff_framework 
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eAppendix 5. Details of Performance Metrics of Each Model 
Note that sensitivity, specificity, prevision, F-score and accuracy vary depending on the threshold of ML models (as shown in ROC 
curves), we fixed specificity at 95% for easier comparison between different models. As shown in eTable 1 to eTable 5, in most cases 
the machine learning model with highest AUROC would have the highest AUPRC too, hence model selection based on either AUROC 
or AUPRC would yield similar results. Such observation is consistent with theory, that if a model dominates in ROC curve, then it also 
dominates in PRC curve1. See reference for detailed proof. When the model is determined, the thresholds can be carefully adjusted based 
on the clinicians’ judgement on the relative weight between sensitivity, specificity, etc.  
eTable8: AUROCs of best machine learning models for pneumonia, acute kidney injury (AKI), deep vein thrombosis (DVT), 
pulmonary embolism (PE) and delirium. 

















































































eTable9: Detailed performance of 5 machine learning models for pneumonia: GBT: Gradient Boosting Tree; LR: Logistic 
Regression; RF: Random Forest; DNN: Deep Neural Network; SVM: Support Vector Machine. 
Model AUROC AUPRC Sensitivity Specificity Precision F-score Accuracy 
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eTable10: Detailed performance of 5 machine learning models for acute kidney injury: GBT: Gradient Boosting Tree; LR: 
Logistic Regression; RF: Random Forest; DNN: Deep Neural Network; SVM: Support Vector Machine. 


























































































































































































































eTable11: Detailed performance of 5 machine learning models for deep vein thrombosis: GBT: Gradient Boosting Tree; LR: 
Logistic Regression; RF: Random Forest; DNN: Deep Neural Network; SVM: Support Vector Machine. 
Model AUROC AUPRC Sensitivity Specificity Precision F-score Accuracy 
InOp 
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eTable12: Detailed performance of 5 machine learning models for pulmonary embolism: GBT: Gradient Boosting Tree; LR: 
Logistic Regression; RF: Random Forest; DNN: Deep Neural Network; SVM: Support Vector Machine. 
Model AUROC AUPRC Sensitivity Specificity Precision F-score Accuracy 
InOp 
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eTable13: Detailed performance of 5 machine learning models for delirium: GBT: Gradient Boosting Tree; LR: Logistic 
Regression; RF: Random Forest; DNN: Deep Neural Network; SVM: Support Vector Machine. 
Model AUROC AUPRC Sensitivity Specificity Precision F-score Accuracy 
InOp 
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eAppendix 6. More on Model Interpretation 
In this section, we show 2 patients with negative predicted risks and 2 patients with positive 
predicted risks. For the risk overview, we created three candidate graphs: a) comparison of the 
patient with respect to the average of patients who had pneumonia (Fig 1.a, 2.a, 3.a, and 4.a), b) 
comparison of the patient with respect to the average of patients who did not have pneumonia 
(Fig 1.b, 2.b, 3.b and 4.b), and c) comparison of patients with respect to the average of patients 
who had pneumonia and the average of patients who did not have (Fig 1.c, 2.c, 3.c and 4.c). For 
the key intraoperative variables (blood pressure in the prediction model of pneumonia), we 
created detailed visualizations to look into it. First, we created a nested pie chart to show how 
much contribution (measured by SHAP values) does each statistical feature make to the 
prediction (Fig 1.d, 2.d, 3.d and 4.d). In the outer circle it shows the average of all patients; and 
in the inner circle it shows the patient-of-interest. Second, we created a bar plot to show how 
much does the value of each statistical feature differentiate from the average of all patients (Fig 
1.e, 2.e, 3.e and 4.e). Each statistical feature was normalized to zero mean and unit variance, 
























eFigure 1: Patient 1 - negative prediction of pneumonia 









eFigure 2: Patient 2 - negative prediction of pneumonia 










eFigure 3: Patient 3 - positive prediction of pneumonia 










eFigure 4: Patient 4- positive prediction of pneumonia 
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eAppendix 7. Model Interpretation on False Positives, False Negatives, True Positives, and True 
Negatives 
In this section, we show example cases of true positives (TP), false positives (FP), true negatives 
(TN) and false negatives (FN) for 5 outcomes based on model interpretation. For the 20 example 
cases, we show: the comparison of patients with respect to the risks of getting pneumonia (TP: 
Fig 6.a, FP: Fig 6.b, TN: Fig 6.c, and FN: Fig 6.d); the comparison of the patient with respect to 
the risks of getting AKI (TP: Fig 7.a, FP: Fig 7.b, TN: Fig 7.c, and FN: Fig 7.d);  the comparison 
of patients with respect to the risks of getting DVT (TP: Fig 8.a, FP: Fig 8.b, TN: Fig 8.c, and 
FN: Fig 8.d);  the comparison of patients with respect to the risks of getting PE (TP: Fig 9.a, FP: 
Fig 9.b, TN: Fig 9.c, and FN: Fig 9.d) and the comparison of patients with respect to the risks of 
getting delirium (TP: Fig 10.a, FP: Fig 10.b, TN: Fig 10.c, and FN: Fig 10.d).  
In each figure, we are showing 4 distinct cases in the prediction of same outcome. In subplots a 
and c, most of the patients’ preoperative and intraoperative data were consistent with historical 
cases of positive/negative patients, which resulted in constantly increasing or decreasing risks. In 
subplots b and d, the patients’ data had mixed effects: some measurements were consistent with 
positive cases but some measurements were consistent with negative cases, hence the overall risk 
fluctuated. Taking Fig. 6 for example, some measurements including albumin, hematocrit were 
weighted as more important in the predictive model of pneumonia, thus the values of these 
measurements misled the overall risk. Note that albumin level in the case of Fig. 6c and 6d were 
missing. In the presence of missingness, machine learning model learned from historical data 
that indication of missing measurement would lower the likelihood of getting pneumonia, 
however, this was not always true and such missingness misled the prediction in Fig. 6d.  
By looking at different scenarios in each outcome, we argue that the model interpretation have 
several advantages than a simple risk score. First, regardless of the correctness of the prediction, 
model interpretation could provide us with the important variables in each case, and how such 
variables affect the prediction risk in comparison with the positive/negative cohorts.  Second, 
when most measurements are consistently contributing towards the same direction, such model 
interpretation could provide clinicians with more confidence in trusting the prediction risks. Last 
but not least, outcomes and input variables may not have a simple causal relationship. In the 
cases of false negatives and false positives, the conflicting factors could highlight the issues of 
wrong data, or alert clinicians the complexity of the patients’ scenario, so that more attention 












eFigure5: Example cases of true positives (TP), false positives (FP), true negatives (TN) and 
false negatives (FN) for getting pneumonia 
 
 







eFigure6: Example cases of true positives (TP), false positives (FP), true negatives (TN) and 
false negatives (FN) for getting AKI 







eFigure7: Example cases of true positives (TP), false positives (FP), true negatives (TN) and 
false negatives (FN) for getting DVT 







eFigure8: Example cases of true positives (TP), false positives (FP), true negatives (TN) and 
false negatives (FN) for getting PE 







eFigure9: Example cases of true positives (TP), false positives (FP), true negatives (TN) and 
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eAppendix 8. Three Scenarios for Predicting Postoperative Complications 
 
 
eFigure10: Three scenarios for predicting postoperative complications. Scenario 1 occurs at the admission stage and only 
preoperative data is used for surgery planning. Scenario 2 occurs after emergency surgery is performed and only 
intraoperative data is used for handoff process. Scenario 3 occurs after normal surgery with both preoperative and 
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